Bioalliance Pharma S.A.
Records under this name other than patents Bioalliance Pharma S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Bioalliance Pharma S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,791,127 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,747,896 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,211,466 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,089,559 | Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,592,434 | Mucoadhesive Buccal Tablets for the Treatment of Orofacial Herpes Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,651,698 | Prolonged release bioadhesive therapeutic systems Formerly held Term ended Term ended Aug 15, 2024 · From the USPTO record | Term ended | Term ended Aug 15, 2024 | From the USPTO record |
| US 9,192,599 | Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers Formerly held Lapsed on the fee record Ended Nov 24, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2023 | From the USPTO record |
| US 8,518,442 | Prolonged release bioadhesive therapeutic systems Formerly held Term ended Term ended Nov 21, 2022 · From the USPTO record | Term ended | Term ended Nov 21, 2022 | From the USPTO record |
| US 6,916,485 | Prolonged Release Bioadhesive Therapeutic Systems Formerly held Term ended Term ended Sep 11, 2022 · High confidence | Term ended | Term ended Sep 11, 2022 | High confidence |
| US 9,763,874 | Nanoparticles loaded with chemotherapeutic antitumoral drug Formerly held Lapsed on the fee record Ended Sep 19, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 19, 2021 | From the USPTO record |